Page 212 - Read Online
P. 212

Infante et al.                                                                                                                                                                                                     PML after rituximab

           INTRODUCTION                                       He was treated with chlorambucil in 2012, followed
                                                              by  6  cycles  of  fludarabine,  cyclophosphamide  and
           Progressive multifocal encephalopathy  (PML) is a   lenalidomide in 2013, with complete response; he was
           demyelinating infectious disease of the central nervous   then treated with rituximab and steroids for hemolytic
           system caused  by reactivation  of John Cunningham   anemia (for 4 weeks in 2014) with complete regression.
           polyomavirus (JCV) and often leads to death resulting
           from progressive oligodendrocytes infection and    In March 2016, he was admitted to the emergency
           lysis .  Prior  to  human  immunodeficiency  virus  era,   department for acute dizziness and ataxia followed,
               [1]
           this infection was seen in severely immunosuppressed   after  one day,  by dysarthria and left  limbs ataxia. A
           patients, including  individuals  with hematological   cerebral  unenhanced  computed tomography  (CT)
           malignancies,  organ  transplantation  or chronic
           inflammatory conditions, such autoimmune disorders,   scan showed diffuse ipodensity of the left cerebellum
           with an incidence of 4 cases/100,000 [2-4] .       and the middle cerebellar peduncle without mass effect
                                                              [Figures 1 and 2].
           Clinical presentation is  heterogeneous: PML  usually
           begins as a subacute illness that typically evolves from
           focal  or  multifocal  neurological  deficits  progressing
           over days to weeks, leading to severe disability and,
           ultimately, to death. In some cases focal neurological
           syndromes may present acutely and can be mistaken
           for stroke. The ratio of cerebral to brainstem involvement
           is estimated approximately to be 10:1. For reasons that
           are unclear, brainstem involvement is more common in
           acquired immunodeficiency syndrome patients, with a
           ratio of approximately 4:1 .
                                  [1]
           Diagnosis of PML is clinical and radiological, principally
           magnetic resonance imaging (MRI) based; diagnosis
           is  then  confirmed  by  demonstration  of  JCV  DNA  in
           the cerebrospinal fluid by polymerase chain reaction
           (PCR) test [4,5] .

                                                              Figure 1: Brain computer tomography scan without contrast
           Key MRI diagnostic  features are: (1) cortical and   showing ipodensity al left cerebellar hemisphere without mass
           deep  cerebellar nuclei  (in  infratentorial  involvement)   effect
           sparing; (2) absence of mass effect on subarachnoid
           or ventricular spaces and on adjacent areas; and
           (3) lack  of  contrast enhancement (CE).  Diffusion-
           weighted  images (DWI) sequences  are also able to
           assess the extension of white matter lesions; regions
           with increased DWI intensity  represent  white  matter
           areas characterized by reduced water diffusion due to
           cytotoxic edema [2-6] .

           Demyelination   is  usually  multifocal,  involving
           hemispheric white matter (parietal, frontal and occipital
           lobes) and/or cerebellar peduncles. In literature, rare
           cases of posterior fossa localization are described .
                                                       [7]
           To date, there is no established therapy for PML and
           the treatment is mostly supportive .
                                         [8]
           CASE REPORT

           The patient was a 75-year-old male with a previously   Figure 2: Brain computer tomography scan without contrast
                                                              showing ipodensity al left cerebellar hemisphere spreading to
           (2012)  diagnosed  chronic  lymphocytic  leukemia.   middle cerebellar peduncle
            212                                                                Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ October 19, 2017
   207   208   209   210   211   212   213   214   215   216   217